Results 251 to 260 of about 258,704 (366)
Hormone replacement therapy for menopausal mood swings and sleep quality: The current evidence. [PDF]
Borozan S+2 more
europepmc +1 more source
Contemporary Perspectives on Chronic Renal Disorders
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok+5 more
wiley +1 more source
Is a Dense Mammographic Parenchymal Pattern a Contraindication to Hormonal Replacement Therapy? [PDF]
Irma E. Saarenma Tiina M. Salminen
openalex +1 more source
Association of Hormone Replacement Therapy with Inflammatory Bowel Disease Risk in Women with Menopausal Disorders: A Population-Based Retrospective Cohort Study. [PDF]
Tseng YT, Chen II, Wang CH.
europepmc +1 more source
We designed and synthesized novel mannose‐6‐phosphate (M6P) derivatives to enhance their binding affinity for the CI‐M6P/IGF2 receptor, which plays a key role in lysosomal targeting. Using a fluorescence polarization assay, we evaluated di‐, tri‐, and penta‐M6P peptides and modified M6P analogs.
Lucie Mrázková+11 more
wiley +1 more source
Herein, a sequential acyl‐thiol‐ene/S‐deacetylation protocol for selective installation of thiol residues onto synthetic peptides, on‐resin, is demonstrated. The hydrothiolation/S‐deacetylation protocol offers a novel synthetic tool for direct peptide conjugation on‐resin and for the preparation of novel disulfide containing neuropeptides displaying ...
Nikita Ostrovitsa+5 more
wiley +1 more source
Research status of hormone replacement therapy on mood and sleep quality in menopausal women. [PDF]
Wang XJ.
europepmc +1 more source
Work presented here details the design and characterize novel G protein‐gated inwardly rectifying potassium channels (GIRK)1/2 activators. A new 4,4‐difluorocyclohexylpyrazole have been identified that confers improved potency and selectivity for GIRK1/2 versus GIRK1/4.
Sumaiya Nahid+8 more
wiley +1 more source